{
  "id": "5522fadb7b523f2123000001",
  "type": "yesno",
  "question": "Are Notch mutations related to T-cell Acute Lymphoblastic Leukemia (T-ALL)?",
  "ideal_answer": "Notch1 is a transmembrane receptor that is frequently mutated in human T-cell acute lymphoblastic leukemia (T-ALL). Activating mutations in NOTCH1, an essential regulator of T cell development, are frequently found in human T cell acute lymphoblastic leukemia (T-ALL). ",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/24301524",
    "http://www.ncbi.nlm.nih.gov/pubmed/24252593",
    "http://www.ncbi.nlm.nih.gov/pubmed/18056171",
    "http://www.ncbi.nlm.nih.gov/pubmed/23033986",
    "http://www.ncbi.nlm.nih.gov/pubmed/23730497",
    "http://www.ncbi.nlm.nih.gov/pubmed/24401270",
    "http://www.ncbi.nlm.nih.gov/pubmed/24140475",
    "http://www.ncbi.nlm.nih.gov/pubmed/21463127",
    "http://www.ncbi.nlm.nih.gov/pubmed/20967796",
    "http://www.ncbi.nlm.nih.gov/pubmed/20008221",
    "http://www.ncbi.nlm.nih.gov/pubmed/17575125",
    "http://www.ncbi.nlm.nih.gov/pubmed/20015880",
    "http://www.ncbi.nlm.nih.gov/pubmed/16707600",
    "http://www.ncbi.nlm.nih.gov/pubmed/24068942",
    "http://www.ncbi.nlm.nih.gov/pubmed/23022380",
    "http://www.ncbi.nlm.nih.gov/pubmed/18184405",
    "http://www.ncbi.nlm.nih.gov/pubmed/25493453",
    "http://www.ncbi.nlm.nih.gov/pubmed/21263446",
    "http://www.ncbi.nlm.nih.gov/pubmed/21302811"
  ],
  "snippets": [
    {
      "text": "Notch receptors participate in a highly conserved signalling pathway that regulates normal development and tissue homeostasis in a context- and dose-dependent manner. Deregulated Notch signalling has been implicated in many diseases, but the clearest example of a pathogenic role is found in T-cell lymphoblastic leukaemia/lymphoma (T-LL), in which the majority of human and murine tumours have acquired mutations that lead to aberrant increases in Notch1 signalling.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20967796",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "NOTCH proteins (NOTCH1, NOTCH2, NOTCH3 and NOTCH4) play crucial roles in embryonic development. Also, mounting evidence indicates that NOTCH contributes to the pathogenesis of hematopoietic and solid malignancies. Recent studies reported a high incidence of gain-of-function mutations of the NOTCH1 gene in T-cell acute lymphoblastic leukemias (ALL). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18184405",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our data indicate that NOTCH1 is mutated in T-ALL, but not in other common human cancers, and that NOTCH2, NOTCH3 and NOTH4 genes are rarely mutated in common human cancers. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18184405",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Notch signaling pathway plays a critical role in maintaining the balance between cell proliferation, differentiation and apoptosis, and is a highly conserved signaling pathway that regulates normal development in a context- and dose-dependent manner. Dysregulation of Notch signaling has been suggested to be key events in a variety of hematological malignancies. Notch1 signaling appears to be the central oncogenic trigger in T cell acute lymphoblastic leukemia (T-ALL), in which the majority of human malignancies have acquired mutations that lead to constitutive activation of Notch1 signaling.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24252593",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "T-cell acute lymphoblastic leukemia (T-ALL) is characterized as a high-risk stratified disease associated with frequent relapse, chemotherapy resistance, and a poorer prognostic outlook than B-precursor ALL. Many of the challenges in treating T-ALL reflect the lack of prognostic cytogenetic or molecular abnormalities on which to base therapy, including targeted therapy. Notch1 activating mutations were identified in more than 50% of T-ALL cases and can be therapeutically targeted with \u03b3-secretase inhibitors (GSIs). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24140475",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Notch1 is a transmembrane receptor that is frequently mutated in human T-cell acute lymphoblastic leukemia (T-ALL). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24068942",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) is characterized by aberrant activation of NOTCH1 in over 60% of T-ALL cases. The high prevalence of activating NOTCH1 mutations highlights the critical role of NOTCH signaling in the pathogenesis of this disease and has prompted the development of therapeutic approaches targeting the NOTCH signaling pathway. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23730497",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Activating mutations in NOTCH1, an essential regulator of T cell development, are frequently found in human T cell acute lymphoblastic leukemia (T-ALL). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23022380",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "NOTCH signaling pathway is essential in T-cell development and NOTCH1 mutations are frequently present in T-cell acute lymphoblastic leukemia (T-ALL).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16707600",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Activating Notch-1 mutations are frequent in T-cell acute lymphoblastic leukemia (T-ALL), occurring in >50% of patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18056171",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mutations in NOTCH1/FBXW7 activate NOTCH signaling and are of prognostic significance in patients with T-cell acute lymphoblastic leukemia (T-ALL).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25493453",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Gain-of-function mutations in Notch-1 have been reported in more than 50% of human T-cell acute lymphoblastic leukemia (T-ALL).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21302811",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Notch signaling is of crucial importance in normal T-cell development and Notch 1 is frequently mutated in T-cell acute lymphoblastic leukemias (T-ALL), leading to aberrantly high Notch signaling.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17575125",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Activation of the Notch pathway occurs commonly in T acute lymphoblastic leukemia (T-ALL) because of mutations in Notch1 or Fbw7 and is involved in the regulation of cell proliferation and survival.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21263446",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "T-cell acute lymphoblastic leukemia (T-ALL) patients frequently display NOTCH1 activating mutations and Notch can transcriptionally down-regulate the tumor suppressor PTEN.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20015880",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The identification of activating mutations in NOTCH1 in over 50% of T-cell acute lymphoblastic leukemias (T-ALL) has generated major interest in the elucidation of the mechanisms of transformation downstream of oncogenic NOTCH and in the targeting of the NOTCH signaling pathway in this disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20008221",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: In T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL), activating mutations of NOTCH1 are observed in more than 50% of cases, whereas the t(7;9)(q34;q34) involving NOTCH1 at 9q34 and TRB@ at 7q34 is an extremely rare but recurrent translocation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23033986",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Activating mutations in NOTCH1 consitute the most prominent genetic abnormality in T-cell acute lymphoblastic leukemia (T-ALL).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21463127",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "T cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer that is frequently associated with activating mutations in NOTCH1 and dysregulation of MYC",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24401270",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Notch signaling pathway has been recognized as a key factor for the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL), because of the high incidence of activating mutations of Notch1",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24301524",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Notch signaling is of crucial importance in normal T-cell development and Notch 1 is frequently mutated in T-cell acute lymphoblastic leukemias (T-ALL), leading to aberrantly high Notch signaling",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17575125",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "NOTCH signaling pathway is essential in T-cell development and NOTCH1 mutations are frequently present in T-cell acute lymphoblastic leukemia (T-ALL)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16707600",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Activating Notch-1 mutations are frequent in T-cell acute lymphoblastic leukemia (T-ALL), occurring in >50% of patients",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18056171",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Gain-of-function mutations in Notch-1 have been reported in more than 50% of human T-cell acute lymphoblastic leukemia (T-ALL)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21302811",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.disease-ontology.org/api/metadata/DOID:5603"
  ],
  "exact_answer": "Yes"
}